Genetic Basis of Susceptibility to Environmentally Induced Neural Tube Defects

Abstract: Neural tube defects (NTDs) are among the most common of all human congenital defects, with multifactorial etiologies comprising both environmental and genetic components. Several murine model systems have been developed in an effort to elucidate genetic factors regulating expression of NTDs. Strain‐dependent differences in susceptibility to teratogenic insults and altered patterns of gene expression observed within the neuroepithelium of affected embryos support the hypothesis that subtle genetic changes can result in NTDs. Since several affected genes are folate‐regulated, transgenic knockout mice lacking a functional folate receptor were developed. Nullizygous embryos died in utero with significant morphological defects, supporting the critical role of folic acid in early embryogenesis. While epidemiological studies have not established an association between polymorphisms in the human folate receptor gene and NTDs, it is known that folate supplementation reduces infant NTD risk. Continued efforts are therefore necessary to reveal the mechanism by which folate works and the nature of the gene(s) responsible for human NTDs.

[1]  G. Shaw,et al.  Lack of association between mutations in the folate receptor-α gene and spina bifida , 1998 .

[2]  J. A. Calvin,et al.  Arsenic-induced alterations in embryonic transcription factor gene expression: implications for abnormal neural development. , 1996, Developmental genetics.

[3]  EduardoE. Castilla.  VALPROIC ACID AND SPINA BIFIDA , 1983, The Lancet.

[4]  L. Sever,et al.  Teratogen update: valproic acid. , 1987, Teratology.

[5]  H. Nau,et al.  Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse. , 1987, Life sciences.

[6]  N. Hessol,et al.  The prevalence at birth of congenital malformations in communities near the Hanford site. , 1988, American journal of epidemiology.

[7]  H. Nau,et al.  Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent. , 1991, Reproductive toxicology.

[8]  J. Erickson.  Racial variations in the incidence of congenital malformations , 1976, Annals of human genetics.

[9]  OpenStax.  The Brain and Spinal Cord * , 2022 .

[10]  R. G. Anderson,et al.  Potocytosis: sequestration and transport of small molecules by caveolae. , 1992, Science.

[11]  D. Boomsma,et al.  Breastfeeding and neurological status , 1995, The Lancet.

[12]  L. Edmonds,et al.  Maternal fever and neural tube defects. , 1980, Teratology.

[13]  L. Sever,et al.  Looking for causes of neural tube defects: where does the environment fit in? , 1995, Environmental health perspectives.

[14]  G. Bennett,et al.  Phenytoin-induced alterations in craniofacial gene expression. , 1999, Teratology.

[15]  L B Holmes,et al.  Etiologic heterogeneity of neural-tube defects. , 1976, The New England journal of medicine.

[16]  C. Bolliger,et al.  Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning. , 1992, Respiration; international review of thoracic diseases.

[17]  J. Eberwine,et al.  Complementary DNA synthesis in situ: methods and applications. , 1992, Methods in enzymology.

[18]  P. Baghurst,et al.  Congenital malformations and maternal drinking water supply in rural South Australia: a case-control study. , 1984, American journal of epidemiology.

[19]  B. Kamen,et al.  Identification of a point mutation in the folate receptor gene that confers a dominant negative phenotype. , 1995, Cancer research.

[20]  G. Hall,et al.  MALIGNANT HYPERTHERMIA: A HUMAN AND PORCINE STRESS SYNDROME? , 1975, The Lancet.

[21]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[22]  G. S. Sohal,et al.  Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. , 1986, Teratology.

[23]  K. Nakano.  Anencephaly: A Review , 1972 .

[24]  G. Shaw,et al.  Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. , 1996, Teratology.

[25]  G. Thériault,et al.  Evaluation of the association between birth defects and exposure to ambient vinyl chloride. , 1983, Teratology.

[26]  J. Golden,et al.  Strain differences in heat-induced neural tube defects in mice. , 1986, Teratology.

[27]  T. Matte,et al.  Case-control study of congenital defects and parental employment in health care. , 1993, American journal of industrial medicine.

[28]  Richard G. W. Anderson,et al.  Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development , 1999, Nature Genetics.

[29]  D. Brunoni,et al.  Birth defects and environmental pollution: the Cubatão example. , 1985, Progress in clinical and biological research.

[30]  R. Finnell.  Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects. , 1991, Pharmacology & toxicology.

[31]  J. Brender,et al.  Paternal occupation and anencephaly. , 1990, American journal of epidemiology.

[32]  L. Beckman.  The Rönnskär smelter-occupational and environmental effects in and around a polluting industry in northern Sweden. , 1978 .

[33]  H. Nau,et al.  Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. , 1992, Neurology.

[34]  T. Shepard,et al.  MATERNAL HYPERTHERMIA AS A POSSIBLE CAUSE OF ANENCEPHALY , 1978, The Lancet.

[35]  Lammer Ej,et al.  Retinoic Acid Embryopathy , 1985 .

[36]  G. Cassady,et al.  Acute maternal arsenic intoxication with neonatal death. , 1969, American journal of diseases of children.

[37]  Evans Da.  Letter: Coeliac disease and HL-A8. , 1973 .

[38]  Diana Brahams,et al.  Confidentiality and under-age girls who seek contraceptive advice. , 1983, Lancet.

[39]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[40]  J. Ragoussis,et al.  Genomic organization of the human folate receptor genes on chromosome 11q13. , 1992, Genomics.

[41]  L. Penrose.  Genetics of anencephaly. , 2008, Journal of mental deficiency research.

[42]  P. Corey,et al.  Water nitrates and CNS birth defects: a population-based case-control study. , 1988, Archives of environmental health.

[43]  Broadhurst Ad.  L-tryptophan verses E.C.T. , 1970 .

[44]  K. Rosenman,et al.  Central nervous system malformations in relation to two polyvinyl chloride production facilities. , 1989, Archives of environmental health.

[45]  E. Robert,et al.  MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS , 1982, The Lancet.

[46]  P. Holmberg.  CENTRAL-NERVOUS-SYSTEM DEFECTS IN CHILDREN BORN TO MOTHERS EXPOSED TO ORGANIC SOLVENTS DURING PREGNANCY , 1979, The Lancet.

[47]  R. Finnell,et al.  Role of arsenic as a reproductive toxin with particular attention to neural tube defects. , 1996, Journal of toxicology and environmental health.

[48]  G. Shaw,et al.  Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally , 1995, The Lancet.

[49]  D. Lindhout,et al.  Teratogenicity of Antiepileptic Drug Combinations with Special Emphasis on Epoxidation (of Carbamazepine) , 1984, Epilepsia.

[50]  D. Lindhout,et al.  IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS , 1986, The Lancet.

[51]  K J Rothman,et al.  Chemical quality of maternal drinking water and congenital heart disease. , 1988, International journal of epidemiology.

[52]  R. G. Anderson,et al.  Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. , 1989, The Journal of clinical investigation.

[53]  J. A. Calvin,et al.  Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. , 1996, Reproductive toxicology.

[54]  E. Robert.  Valproic acid and spina bifida: a preliminary report--France. , 1982, MMWR. Morbidity and mortality weekly report.

[55]  L. Edmonds,et al.  Congenital central nervous system malformations and vinyl chloride monomer exposure: a community study. , 1978, Teratology.

[56]  J. Eberwine,et al.  Analysis of gene expression in single live neurons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Lammer Ej,et al.  Teratogen update: valproic acid. , 1987, Teratology.

[58]  H. Nau,et al.  Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. , 1992, Neurology.

[59]  R. Mccurdy,et al.  Chemicals, birth defects and stillbirths in New Brunswick: associations with agricultural activity. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[60]  J. Eberwine,et al.  Lack of concordance between heat shock proteins and the development of tolerance to teratogen-induced neural tube defects. , 1993, Developmental genetics.

[61]  V. Zurawski,et al.  Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. , 1992, Cancer research.

[62]  G. Shaw,et al.  Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987. , 1994, Teratology.

[63]  H. Blom,et al.  Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? , 1994, Metabolism: clinical and experimental.

[64]  J. Little,et al.  Epidemiology and control of neural tube defects , 1993 .

[65]  J. Erickson.  Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study. , 1992, Teratology.

[66]  F. Rosa,et al.  Spina bifida in infants of women treated with carbamazepine during pregnancy. , 1991, The New England journal of medicine.